Notes / Company Asston Pharmaceuticals Ltd. APL BSE 544445 ISIN INE0SJX01015 Pharmaceuticals Fundamentals Market cap₹68.95 cr P/E17.84× ROE40.35% Debt / equity0.68 52-week range 61.02 — 126.00 Research on Tijori Finance The timeline — 1 note on Asston Pharmaceuticals Ltd. July 2026 02 Jul 26 · 6:26 PM IST Lead Lead · Micro cap Asston Pharma to raise ₹27.7 cr via preferential issue, 28% dilution The nano-cap pharma company is selling a 28% stake to non-promoter investors, including a 12% block to Vijay Rathee, in a deal that could reshape control and pricing. Verify on exchange BSE filings for APL NSE filings for APL Tijori Finance company page